Prelude Therapeutics, Inc. (PRLD)
3.88
-0.22
(-5.37%)
USD |
NASDAQ |
Oct 30, 16:00
3.923
+0.04
(+1.11%)
After-Hours: 20:00
Prelude Therapeutics Price : 3.88 for Oct. 30, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | 4.02 | 4.105 | 3.82 | 3.88 | 218104.0 |
| Oct 29, 2026 | 4.16 | 4.25 | 4.07 | 4.10 | 201320.0 |
| Oct 28, 2026 | 3.89 | 4.16 | 3.79 | 4.14 | 475868.0 |
| Oct 27, 2026 | 3.70 | 3.94 | 3.60 | 3.88 | 277485.0 |
| Oct 26, 2026 | 3.63 | 3.74 | 3.40 | 3.70 | 236859.0 |
| Oct 23, 2026 | 3.59 | 3.69 | 3.41 | 3.63 | 288577.0 |
| Oct 22, 2026 | 3.61 | 3.73 | 3.47 | 3.60 | 323758.0 |
| Oct 21, 2026 | 3.56 | 3.78 | 3.473 | 3.65 | 608329.0 |
| Oct 20, 2026 | 3.40 | 3.61 | 3.35 | 3.53 | 362765.0 |
| Oct 19, 2026 | 3.28 | 3.42 | 3.26 | 3.39 | 1.589M |
| Oct 16, 2026 | 3.32 | 3.41 | 3.18 | 3.26 | 479871.0 |
| Oct 15, 2026 | 3.30 | 3.44 | 3.20 | 3.32 | 400250.0 |
| Oct 14, 2026 | 3.50 | 3.50 | 3.205 | 3.23 | 489014.0 |
| Oct 13, 2026 | 3.74 | 3.897 | 3.43 | 3.56 | 676364.0 |
| Oct 12, 2026 | 3.91 | 3.94 | 3.74 | 3.74 | 196549.0 |
| Oct 09, 2026 | 3.87 | 4.03 | 3.85 | 3.89 | 341648.0 |
| Oct 08, 2026 | 3.77 | 3.95 | 3.66 | 3.88 | 424098.0 |
| Oct 07, 2026 | 3.835 | 3.93 | 3.69 | 3.83 | 454698.0 |
| Oct 06, 2026 | 3.78 | 3.82 | 3.68 | 3.81 | 383739.0 |
| Oct 05, 2026 | 3.68 | 3.81 | 3.55 | 3.77 | 325275.0 |
| Oct 02, 2026 | 3.75 | 3.815 | 3.63 | 3.67 | 742041.0 |
| Oct 01, 2026 | 3.90 | 3.940 | 3.59 | 3.79 | 502503.0 |
| Sep 30, 2026 | 4.02 | 4.02 | 3.86 | 3.91 | 703218.0 |
| Sep 29, 2026 | 3.95 | 4.00 | 3.83 | 3.96 | 458490.0 |
| Sep 28, 2026 | 3.845 | 3.98 | 3.72 | 3.91 | 496451.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Q32 Bio, Inc. | 8.91 |
| Intellia Therapeutics, Inc. | 12.47 |
| Twist Bioscience Corp. | 152.78 |
| Beam Therapeutics, Inc. | 27.23 |
| Revolution Medicines, Inc. | 191.31 |
Price Related Metrics
| PS Ratio | 13.84 |
| Price to Book Value | 2.314 |
| Earnings Yield | -20.30% |
| Market Cap | 309.46M |